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function
Jasvinder A Singh1,2,3,4* and David G Lewallen3Abstract
Background: To characterize whether medical comorbidities, depression and anxiety predict patient-reported
functional improvement after total knee arthroplasty (TKA).
Methods: We analyzed the prospectively collected data from the Mayo Clinic Total Joint Registry for patients who
underwent primary or revision TKA between 1993–2005. Using multivariable-adjusted logistic regression analyses,
we examined whether medical comorbidities, depression and anxiety were associated with patient-reported
subjective improvement in knee function 2- or 5-years after primary or revision TKA. Odds ratios (OR), along with
95% confidence intervals (CI) and p-value are presented.
Results: We studied 7,139 primary TKAs at 2- and 4,234 at 5-years; and, 1,533 revision TKAs at 2-years and 881 at
5-years. In multivariable-adjusted analyses, we found that depression was associated with significantly lower odds
of 0.5 (95% confidence interval [CI]: 0.3 to 0.9; p = 0.02) of ‘much better’ knee functional status (relative to same or
worse status) 2 years after primary TKA. Higher Deyo-Charlson index was significantly associated with lower odds of
0.5 (95% CI: 0.2 to 1.0; p = 0.05) of ‘much better’ knee functional status after revision TKA for every 5-point increase
in score.
Conclusions: Depression in primary TKA and higher medical comorbidity in revision TKA cohorts were associated
with suboptimal improvement in index knee function. It remains to be seen whether strategies focused at
optimization of medical comorbidities and depression pre- and peri-operatively may help to improve TKA
outcomes. Study limitations include non-response bias and the use of diagnostic codes, which may be associated
with under-diagnosis of conditions.
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Total knee arthroplasty (TKA) is a very successful sur-
gery for patients with end-stage arthritis. TKA is associ-
ated with significant improvements in pain, function
and quality of life [1]. Related to the obesity epidemic,
increasing longevity and the expansion of TKA indica-
tions to both younger and older patients, the annual
incidence of TKA is increasing at an exponential rate
[2,3]. Post-TKA functional limitations constitute a sig-
nificant problem. We need a better understanding of
factors associated with failure to improve index knee
function after TKA.
Previous studies examining the effect of medical and
psychological comorbidity on knee function after TKA
have provided contradictory results. Some studies found
that higher medical comorbidity was associated with
poorer function [4-6], but others reported no association
[7-11]. Similarly, some studies reported that depression
was associated with poor functional outcomes after TKA
[12-14], but others did not [15,16]. While the reasons for
these contradictory findings are unclear, there is clearly a
lack of consistent evidence of association of medical and
psychological comorbidity with knee function after TKA.
Not surprisingly, a recent systematic review of psychological
factors affecting outcomes of knee or hip arthroplasty
concluded “…strong evidence was found that preoperative
depression had no influence on postoperative functioning”
[14]. Four key limitation of most previous studies were that:
(1) they consisted of small sample sizes and were likely
underpowered; (2) multivariable-adjustment for poten-
tial confounders was not done in all studies, thereby in-
creasing the possibility of bias; (3) they provided a mean
change in function score at the cohort level (averaging
of excellent, good and poor results), which is difficult
to extrapolate to patient level benefit, varying in their
improvement in function after TKA; and (4) very few
studies included patients with revision TKA. An easier
way to understand arthroplasty results is to examine the
proportion of patients who achieve a clinically meaning-
ful improvement in function, reported only rarely in
arthroplasty studies [17]. Such information can be very
helpful to patients and policy makers. Thus, we need
better-designed studies. The aim of this study was to
examine whether medical and psychological comorbidity
at the time of TKA associated with a clinically meaningful
function improvement after TKA. We hypothesized that
higher medical comorbidity, depression and anxiety at the
time of TKA, will each be independently associated with
poorer patient-reported subjective functional outcome
after primary and revision TKA.
Methods
We describe the methods and results of this observa-
tional study as recommended in the Strengthening ofReporting in Observational studies in Epidemiology
(STROBE) statement [18].
Data source and study population
We used prospectively collected data from the Mayo
Clinic Total Joint Registry. The Mayo Clinic Institutional
Review Board approved the study and waived the need
for patient consent. The Mayo Clinic Total Joint Registry
captures data for all patients undergoing TKA using a
validated standardized questionnaire, the Mayo knee ques-
tionnaire, that has construct validity and reproducibility
[19]. Mayo knee questionnaire includes questions asses-
sing pain and function, similar to the Knee Society Scale
[20], the most commonly used outcome instrument in
TKA patients. The Mayo knee questionnaire was adminis-
tered to patients during an in-person clinic visit, by mail
or by a phone call by trained, dedicated registry staff, at
2- and 5-year time-points post-arthroplasty. Patients
were included in this study if they had undergone a pri-
mary or revision TKA during 1993–2005 and completed
the patient questionnaire at 2- or 5-years post-TKA [21].
Outcome of interest
Improvement in self-reported subjective knee function
compared to the preoperative status was the outcome of
interest. It was assessed with a single question: Com-
pared to your condition before your knee surgery, how
would you rate your knee function? There were four
possible responses: much better, better, same, worse.
Patient responses were categorized into ‘much better’
and ‘better’ categories versus the reference category
comprising of ‘same’, or ‘worse’. This was based on the
assumption that most patients aim and expect to achieve
‘much better’ knee function after TKA, although some
may be satisfied with ‘better’ knee function. Thus, both
constitute clinically meaningful improvements. Same or
worse knee function after TKA, an elective surgical pro-
cedure, is clearly undesirable. This question has been used
previously to assess patient outcomes in knee and hip
arthroplasty populations [21].
Predictors of interest and covariates
The main predictors of interest assessed were medical
and psychological comorbidity at the time of index TKA.
Medical comorbidity was measured using Deyo-Charlson
index, a validated measure of comorbidity [22]. Deyo-
Charlson index consists of a weighted scale of 17 co-
morbidities (including myocardial infarction, congestive
heart failure, peripheral vascular disease, cerebrovascular
disease, dementia, chronic pulmonary disease, connective
tissue disease, peptic ulcer disease, mild liver disease, dia-
betes, diabetes with end-organ damage, hemiplegia, mod-
erate or severe renal disease, tumor without metastasis,
leukemia, lymphoma, moderate or severe liver disease,
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tive score. It is the most commonly used comorbidity
measure in the medical literature and is associated with
important outcomes such as mortality, hospitalization and
outpatient utilization in populations similar to our co-
hort [22-24]. The presence of anxiety or depression was
assessed based on the presence of the respective ICD-9-
CM codes at the time of index TKA, as in previous
studies [25-28].
We adjusted the analyses for important covariates and
confounders, previously shown to be associated with
TKA outcomes (demographics, diagnosis etc.) [10,29-33]
or hypothesized to impact outcome, such as distance
from medical center due to higher complexity of re-
ferred patients versus local patients and differences in
expectations which is associated with TKA outcomes
[34-36]. Data on these covariates/confounders were ob-
tained from the joint registry and institutional clinical
databases. Multivariable-adjusted analyses included the
following covariates and confounders:
(1) Demographics: age, categorized as ≤60, >60-70, >70-
80, >80, as previously [29,37]; gender; and body
mass index (BMI), categorized as normal or
underweight, <25, overweight, 25–29.9, obese,
30–34.9, very obese, 35–39.9, or extremely
obese, ≥40 as previously, as per WHO
classification [38];
(2) American Society of Anesthesiology (ASA)
Physical Status score, categorized as class I-II vs.
III-IV, as previously [26,39], a validated measure of
peri-operative mortality and immediate
post-operative morbidity [40];
(3) Distance from medical center (0–100 miles, >100-
500 miles, >500 miles), categorized as previously
[26,30], calculated by using zip codes and country
codes from the patients’ registration records at the
time of surgery (if available) or at present;
(4) Operative diagnosis: osteoarthritis, rheumatoid/
inflammatory arthritis, or other (avascular necrosis,
fracture etc.) for primary TKA; loosening/wear/
osteolysis, dislocation/bone or prosthesis fracture/
instability/non-union or failed prior arthroplasty
with components removed/infection for revision
TKA; and
(5) Implant fixation: cemented or uncemented/hybrid,
for primary TKA only.Statistical analyses
We used univariate logistic regression models to assess
the crude (unadjusted) association between medical co-
morbidity, anxiety and depression and the improvement
in knee function 2- and 5-years after primary or revisionTKA. Multivariable-adjusted models were used to de-
crease confounding bias by including all pre-specified
covariates significantly associated with outcome and po-
tential confounders. Multivariable-adjusted models in-
cluded Deyo-Charlson index, anxiety, depression, age,
gender, BMI, ASA class, operative diagnosis, distance
from the medical center (for both primary and revision
TKA) and implant fixation (primary TKA only). Odds
ratios (OR), 95% confidence intervals (CI), and p-values
were reported. A p-value ≤0.05 was considered statisti-
cally significant. All regression analyses used a general-
ized estimating equations (GEE) approach to adjust the
standard errors for the correlation between observa-
tions on the same subject due to both knees having
been replaced and/or multiple operations on the same
knee. We used Statistical Package for the Social Sciences
(SPSS) version 19.0 (Chicago, IL) to perform analyses.
IRB approval
This study was approved by the Mayo Clinic Institutional
Review Board and all investigations were conducted in
conformity with ethical principles of research.
Results
We studied 7,139 primary TKAs at 2- and 4,234 at 5-years
and 1,533 revision TKAs at 2- and 881 at 5-years. For the
primary TKA 2-year cohort, the mean age was 68 years,
18% were 60 years or younger, 9% had BMI of 40 kg/m2 or
more and 56% were women. Eleven percent had depres-
sion, 6% had anxiety, 8% had heart disease, mean Deyo-
Charlson index was 1.2, 98% implants were uncemented
and osteoarthritis was the underlying diagnosis in 94%
(Table 1). Other demographic and clinical characteristics
are provided in Table 1. Survey response rates for primary
or revision TKA were 65% and 57% at 2-years and 57%
and 48% at 5 years, respectively. For primary TKA, men,
older age and a diagnosis of osteoarthritis had higher like-
lihood and patients with higher ASA class, higher Deyo-
Charlson score and living >500 miles from the medical
center had a lower likelihood of responding to the survey
(Table 2). Similar characteristics were associated with
non-response in the revision TKA group (Table 2).
Depression, anxiety and Improvement in Knee Function
after Primary TKA
At 2-years after primary TKA, 87% reported much better
and 10% better knee function compared to preoperatively,
and at 5-years, 85% and 10%, respectively. At 2-year
follow-up, depression was associated with lower odds of
much better knee function (p < 0.01) in univariate analyses
(Table 3) as well as lower odds of 0.5 of much better knee
function (p = 0.02) after multivariable-adjustment (Table 4).
Anxiety was not associated with subjective knee function
Table 1 Clinical and demographic characteristics of study cohorts
Primary TKA Revision TKA
2-year (n = 7,139) 5-year (n = 4,234) 2-year (n = 1,533) 5-year (n = 881)
Mean age (±standard deviation) 68 ± 10 68 ± 10 69 ± 10 69 ± 10
Men/Women (%) 44%/56% 45%/55% 49%/51% 51%/49%
Age groups (%)
≤60 yrs 18% 18% 20% 20%
>60-70 yrs 35% 37% 29% 31%
>70-80 yrs 38% 38% 42% 41%
>80 yrs 8% 7% 9% 8%
Body mass index (%)
<25 kg/m2 13% 13% 13% 14%
25-29.9 kg/m2 35% 36% 36% 39%
30-34.9 kg/m2 29% 43% 29% 27%
35-39.9 kg/m2 14% 7% 14% 14%
≥40 kg/m2 9% 7% 7% 5%
American Society of Anesthesiologists (ASA) cass
Class I-II 58% 58% 50% 53%
Class III-IV 42% 41% 50% 47%
Deyo-Charlson index, mean (±standard deviation) 1.2 ± 1.9 1.1 ± 1.9 1.0 ± 1.7 1.0 ± 1.4
Deyo-Charlson comorbidities (%)
Myocardial infarction 5% 5% 4% 4%
Congestive heart failure 4% 3% 4% 2%
Peripheral vascular disease 5% 4% 3% 2%
Cerebrovascular disease 7% 7% 7% 6%
Dementia 0.2% 0.1% 0.2% 0.1%
Chronic Obstructive Pulmonary Disease (COPD) 11% 10% 9% 9%
Ulcer disease 8% 9% 7% 7%
Mild liver disease 2% 2% 1% 2%
Diabetes 9% 8% 10% 7%
Diabetes with organ damage 2% 2% 2% 2%
Hemiplegia 0.3% 0.2% 0.4% 0.3%
Moderate/severe renal disease 6% 4% 4% 2%
Moderate/severe liver disease 0.4% 0.2% 0.5% 0.5%
Metastatic solid tumor 3% 3% 1% 1%
AIDS 0% 0% 0.1% 0.1%
Rheumatologic disease 7% 8% 8% 8%
Other cancer 14% 13% 10% 7%
Psychological comorbidity (%)
Anxiety 6% 5% 5% 3%
Depression 11% 8% 8% 5%
Distance from medical center
<100 miles 53% 51% 32% 34%
100-500 miles 39% 41% 57% 54%
>500 miles 8% 8% 11% 12%
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Table 1 Clinical and demographic characteristics of study cohorts (Continued)
Implant fixation (cement status)
Uncemented 98% 99.7% 0% 0%
Cemented/hybrid 2% 0.3% 100% 100%
Operative diagnosis
Osteoarthritis 94% 93%
Rheumatoid arthritis 4% 4%
Loosening/wear/osteolysis 57% 61%
Dislocation/fracture/instability/non-union 22% 20%
Failed prior arthroplasty with components removed/infection 21% 19%
Other 2% 3%
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or anxiety were not significantly associated with knee
function improvement (Table 4).Depression, anxiety and improvement in knee function
after revision TKA
At 2-years after revision TKA, 65% reported much bet-
ter knee function and 20% better knee function com-
pared to preoperatively, and at 5-years, 63% and 21%,
respectively. In univariate analyses at 5-years after revision
TKA, depression was associated with lower odds of much
better knee function (p = 0.05) (Table 5). In multivariable-
adjusted analyses, this was no longer significant (p = 0.17;
Table 4). At 5-years, in multivariable-adjusted analyses,
neither depression nor anxiety were associated with knee
function.
Medical comorbidity and improvement in knee function
after primary TKA
In univariate analyses, at 2-year follow-up, Deyo-
Charlson index was associated with a statistically non-
significant trend with much better knee function (p = 0.10)
(Table 3). This was no longer significant after multivariable-
adjustment, (p = 0.47) (Table 4). At 5-years, Deyo-Charlson
index was not significantly associated with knee function
improvement (p = 0.25; Table 2).
Medical comorbidity and improvement in knee function
after revision TKA
In univariate analyses at 2 and 5-years after revision
TKA, Deyo-Charlson had a non-statistically significant
association with much better knee function (p = 0.50 and
0.13; Table 5). In multivariable-adjusted analyses, higher
Deyo-Charlson index was associated with significantly
lower odds of 0.5 of much better knee function (p = 0.05;
Table 4) and a trend towards significantly lower odds
of 0.4 of better knee function (p = 0.07; Table 4) at 5-
years. No significant associations were noted at 2-years
(p > 0.20).Discussion
In this study we found that psychological and medical
comorbidity were associated with less optimal improve-
ment in knee function after TKA. Specifically, depression
was associated with suboptimal knee function improve-
ment at 2-years after primary TKA and higher medical
comorbidity score with suboptimal knee function im-
provement at 5-years after revision TKA.
An interesting finding from our study was the associ-
ation of depression with suboptimal improvement in index
knee function 2-years after primary TKA. Several factors
may contribute. Depressed patients are less likely to suc-
cessfully complete rehabilitation therapy [41,42] that is
required post-TKA. They may not follow-up with their
surgeon regularly due to concomitant depression and may
have worse post-operative pain, which may impact adher-
ence with rehabilitation therapy. Optimal physical re-
habilitation after TKA is the key to best results after TKA
[43,44]. The absence of this association in primary TKA at
5-years may be either due to a smaller sample size making
it underpowered analysis or due to “catching up” by pa-
tients with depression after 2-years. The differences in
findings between primary and revision TKA may be due
to differences in patient characteristics (depression, mean
Deyo-Charlson index), the underlying diagnosis and in the
rate of complications between primary and revision TKA.
Two recent studies reported that depression was asso-
ciated with poor functional outcomes after primary TKA
[12,13], while other studies failed to confirm this finding
[15,16]. Two studies examined function only up to 1-
year [12,15], one study at 2-years [16] and one at 5-years
[13]. Most studies had small sample size, making them
underpowered and at risk of missing a significant asso-
ciation. By analyzing a large sample and performing
multivariable-adjusted analyses, our study adds to this
body of knowledge related to association of depression
with improvement in knee function after TKA. Three
key differences between our study and the previous
studies are that we used a large sample and our out-
come was joint-specific and can be interpreted as a
Table 2 Non-responder characteristics




OR (95%)) CI) Events for
non-responders
(3170/7404)
OR (95%)) CI) Events for
non-responders
(1162/2695)





Women 2184/6161 (35.4%) 1860/4191 (44.4%) 621/1402 (44.3%) 509/944 (53.9%)
Men 1634/4796 (34.1%) 0.94 (0.86,1.03) 1310/3213 (40.8%) 0.86‡ (0.78,0.96) 541/1293 (41.8%) 1.10 (0.94, 1.29) 452/898 (50.3%) 0.87 (0.72,1.05)
Age groups n (%)
≤60 yrs 841/2154 (39%) 728/1473 (49.4%) 283/587 (48.2%) 241/413 (58.4%)
>60-70 yrs 1273/3804 (33.5%) 0.79‡ (0.69,0.89) 1065/2641 (40.3%) 0.69‡ (0.60,0.80) 365/816 (44.7%) 0.87 (0.70,1.08) 281/555 (50.6%) 0.73* (0.56,0.96)
>70-80 yrs 1387/4121 (33.7%) 0.79‡ (0.70,0.89) 1142/2759 (41.4%) 0.72‡ (0.63,0.83) 391/1034 (37.8%) 0.65‡ (0.53,0.81) 350/714 (49%) 0.69‡ (0.53,0.89)
>80 yrs 317/878 (36.1%) 0.88 (0.74,1.05) 235/531 (44.3%) 0.81 (0.65,1.01) 123/258 (47.7%) 0.98 (0.72,1.32) 89/160 (55.6%) 0.89 (0.61,1.31)
BMI Categorized
≤24.9 514/1474 (34.9%) 452/1018 (44.4%) 172/375 (45.9%) 136/258 (52.7%)
25-29.9 1287/3766 (34.2%) 0.97 (0.84,1.11) 1061/2586 (41%) 0.87 (0.74,1.02) 375/925 (40.5%) 0.80 (0.63,1.03) 310/655 (47.3%) 0.81 (0.60,1.09)
30-39.9 1644/4712 (34.9%) 1.00 (0.87,1.15) 1346/3169 (42.5%) 0.92 (0.79,1.08) 485/1149 (42.2%) 0.86 (0.68,1.09) 423/784 (54%) 1.05 (0.79,1.41)
≥40 355/960 (37%) 1.10 (0.91,1.32) 299/602 (49.7%) 1.24 (0.99,1.55) 123/229 (53.7%) 1.37 (0.98,1.91) 89/136 (65.4%) 1.70* (1.09,2.66)
ASA
1-2 2021/6136 (32.9%) 1771/4238 (41.8%) 505/1270 (39.8%) 432/899 (48.1%)
3-4 1772/4778 (37.1%) 1.20‡ (1.10,1.31) 1388/3129 (44.4%) 1.11* (1.00,1.23) 651/1414 (46%) 1.29‡ (1.10,1.51) 523/933 (56.1%) 1.38‡ (1.15,1.66)
Deyo-Charlson index
(5 point increase)
1.30‡ (1.17,1.44) 1.07 (0.93,1.22) 1.16 (0.93,1.44) 1.63‡ (1.21,2.20)
Income
>$45 K 1035/3099 (33.4%) 720/1665 (43.2%) 236/548 (43.1%) 163/304 (53.6%)
≤$35 K 699/2098 (33.3%) 1.00 (0.87,1.14) 736/1841 (40%) 0.87 (0.75,1.02) 254/595 (42.7%) 1.98 (0.77,1.25) 243/488 (49.8%) 0.86 (0.64, 1.15)
>$35 K-$45 K 1347/4044 (33.3%) 1.00 (0.89,1.11) 1058/2541 (41.6%) 0.94 (0.82,1.07) 450/1050 (42.9%) 0.99 (0.80,1.23) 363/677 (53.6%) 1.00 (0.76,1.32)
Distance
0-100 miles 1785/5454 (32.7%) 1443/3523 (41%) 390/865 (45.1%) 284/571 (49.7%)
>100-500 miles 1435/4166 (34.4%) 1.08 (0.98,1.19) 1218/2871 (42.4%) 1.06 (0.95,1.19) 602/1449 (41.5%) 0.87 (0.72,1.03) 535/993 (53.9%) 1.18 (0.95, 1.46)
>500 miles or Non-US 476/1017 (46.8%) 1.81‡ (1.55,2.11) 382/709 (53.9%) 1.68‡ (1.40,2.03) 129/293 (44%) 0.96 (0.73,1.27) 103/200 (51.5%) 1.07 (0.77, 1.50)
Underlying diagnoses
Inflammatory arthritis 172/428 (40.2%) 155/344 (45.1%)
Osteoarthritis 3480/10190(34.2%) 0.77* (0.62,0.97) 2872/6794 (42.3%) 0.89 (0.70,1.14)





















Table 2 Non-responder characteristics (Continued)
Loosening/wear or
osteolysis








324/645 (50.2%) 1.50‡ (1.24,1.82) 270/434 (62.2%) 1.87‡ (1.48,2.36)
*P < 0.05; ‡p < 0.01, †p < 0.001.





















Table 3 Univariate association of comorbidity with overall knee statusa at 2- and 5-years after Primary TKA
2-year 5-year









Deyo-Charlsonb Better Not applicable 1.0 (0.7, 1.6) 0.88 Not applicable 1.1 (0.7, 1.6) 0.72
Deyo-Charlsonb Much better Not applicable 0.7 (0.5, 1.1) 0.10 Not applicable 0.8 (0.6, 1.1) 0.14
Anxiety: No Better 299/3,115 = 9.6% 1.0 481/5076 = 9.5% 1.0
Yes Better 24/163 = 14.7% 1.1 (0.5, 2.2) 0.87 40/351 = 11.4% 1.0 (0.5, 1.8) 0.94
Anxiety: No Much better 2657/3,115 = 85.3% 1.0 4407/5076 = 86.8% 1.0
Yes Much better 127/163 = 77.9% 0.6 (0.3, 1.2) 0.14 295/351 = 84.0% 0.8 (0.5, 1.3) 0.37
Depression: No Better 290/3,008 = 9.6% 1.0 450/4851 = 9.3% 1.0
Yes Better 33/270 = 12.2% 0.7 (0.4, 1.2) 0.15 71/576 = 12.3% 1.1 (0.7, 1.8) 0.62
Depression: No Much better 2572/3,008 = 85.5% 1.0 4222/4851 = 87.0% 1.0
Yes Much better 212/270 = 78.5% 0.5 (0.3, 0.8) <0.01 480/576 = 83.3% 0.8 (0.5, 1.3) 0.35
aReference category for overall knee status was a patient response of same or worse index knee status; bper 5-point increase.
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contrast to the use of mean scores on lower limb-specific
instrument (Western Ontario McMaster osteoarthritis
Index, WOMAC) or lower-limb specific/knee-specific
hybrid outcome (such as Knee society score, KSS)
in previous studies. Our study extends and confirmsTable 4 Multivariable-adjusteda odds of Overall Knee status a
Overall knee status at 2 years
Odds ratio (95% CI)
Primary
Deyo-Charlson index (5-point increase)
Better 1.0 (0.6 to 1.7)
Much better 0.9 (0.6 to 1.3)
Anxiety
Better 1.3 (0.6 to 2.8)
Much better 0.9 (0.4 to 1.8)
Depression
Better 0.6 (0.3 to 1.2)
Much better 0.5 (0.3 to 0.9)
Revision
Deyo-Charlson index (5-point increase)
Better 1.5 (0.8 to 2.7)
Much better 1.2 (0.7 to 2.1)
Anxiety
Better 1.3 (0.5 to 3.3)
Much better 0.9 (0.4 to 2.0)
Depression
Better 1.0 (0.5 to 2.0)
Much better 0.6 (0.4 to 1.2)
aMultivariable model additionally adjusted for age to gender to BMI to American So
operative diagnosis to implant fixation (cement status) to Deyo-Charlson index to aprevious findings from the positive studies of depression
and poor functional outcome. Our finding of no associ-
ation of anxiety with functional improvement outcomes
is important and confirms a previous similar finding in
a study with 5-year follow-up [13]. This may be related
to smaller sample size at 5-years.t 2- and 5-years following Primary TKA or Revision TKA
p-value Overall knee status at 5 years p-value
Odds ratio (95% CI)
TKA
0.90 1.0 (0.6 to 1.5) 0.94
0.47 0.8 (0.6 to 1.2) 0.25
0.58 0.9 (0.5 to 1.8) 0.83
0.71 0.8 (0.5 to 1.5) 0.50
0.17 1.1 (0.7 to 2.0) 0.61
0.02 0.9 (0.5 to 1.4) 0.55
TKA
0.21 0.4 (0.2 to 1.1) 0.07
0.48 0.5 (0.2 to 1.0) 0.05
0.60 1.8 (0.4 to 8.0) 0.45
0.75 0.6 (0.1 to 2.9) 0.56
0.98 1.1 (0.4 to 3.2) 0.86
0.17 0.5 (0.2 to 1.4) 0.21
ciety of Anesthesiologist (ASA) class to distance from medical center to
nxiety and depression.
Table 5 Univariate association of comorbidity with overall knee status at 2- and 5-years after Revision TKA
2-year 5-year











Deyo-Charlson indexb Better Not applicable 1.4 (0.8, 2.4) 0.24 Not applicable 0.5 (0.2, 1.1) 0.08
Deyo-Charlson indexb Much better Not applicable 1.2 (0.7, 1.9) 0.50 Not applicable 0.6 (0.3, 1.2) 0.13
Anxiety: No Better 241/1,257 = 19.2% 1.0 151/727 = 20.8% 1.0
Yes Better 18/58 = 31.0% 1.6 (0.7, 3.6) 0.28 8/18 = 44.4% 2.0 (0.5, 7.6) 0.33
Anxiety: No Much better 827/1,257 = 65.8% 1.0 465/727 = 64.0% 1.0
Yes Much better 31/58 = 53.4% 0.8 (0.4, 1.7) 0.54 7/18 = 38.9% 0.6 (0.1, 2.2) 0.40
Depression: No Better 231/1,212 = 19.1% 1.0 147/707 = 20.8% 1.0
Yes Better 28/103 = 27.2% 1.1 (0.6, 2.1) 0.67 12/38 = 31.6% 1.0 (0.4, 2.3) 0.91
Depression: No Much better 802/1,212 = 66.2% 455/707 = 64.4% 1.0
Yes Much better 56/103 = 54.4% 0.7 (0.4, 1.1) 0.13 17/38 = 44.7% 0.4 (0.2, 1.0) 0.05
aReference category for overall knee status was a patient response of same or worse index knee status; bper 5-point increase.
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Charlson index) was significantly associated with subopti-
mal improvement in knee function 5-years after revision
TKA. Previous studies have shown that diabetes and
hypertension are associated with higher post-arthroplasty
complication rates [45]. Poorer functional outcome associ-
ated with higher comorbidity may be partially due to
higher post-operative complication rates. A higher comor-
bidity may also interfere with optimal adherence to phys-
ical rehabilitation. In those with primary TKA, evidence is
contradictory with some studies finding an association of
higher medical comorbidity with poorer function [4-6]
and others no such association [7-11]. We did not note
any significant association of higher comorbidity at base-
line with 2-year outcomes. It is possible that a longer
follow-up allows for a more significant impact of comor-
bidity on TKA outcomes compared to a shorter follow-
up, since chronic diseases get worse with longer disease
duration, in general. In absence of any previous studies
examining patient-level meaningful improvements, these
findings are novel and need confirmation in future studies.
Studies of improvement of knee function after TKA are
important. A $12 million research grant 2010 by the
Agency for Healthcare Research and Quality (AHRQ) to
study factors associated with functional outcomes and
complications after joint replacement is strongly sup-
portive [46]. Our study adds to this growing area of re-
search by studying comorbidity factors as risk factors
for poor patient-reported knee function improvement.
Our study has several limitations. Non-response may
have biased our findings. Survey responders had charac-
teristics previously shown to be associated with better
outcomes (male gender, older age, a diagnosis of osteo-
arthritis, lower ASA class, lower Deyo-Charlson score,
shorter distance to medical center), but it is unclear how
the non-response bias might influence the association ofdepression and medical comorbidity with function out-
comes. A lower response rate at 5-years compared to 2-
years makes these findings more prone to bias. Since
both anxiety and depression were captured based on
presence of a diagnostic code, and psychological comor-
bidities may be under-recognized and under-diagnosed,
it is likely that we missed some cases. This might have
biased our estimates towards null, and we may have
missed some important associations of anxiety and de-
pression with outcomes. A retrospective study design did
not allow us to have confirmation of depression/anxiety
diagnosis by examination by a psychologist of psychiatrist.
However, the prevalence of depression is similar to the 9-
15% reported in studies using validated instruments for
depression [47-49]. Whether the “much better” is truly dif-
ferent from “better” response on this ordinal scale can not
be determined in this study; however, this ordinal response
is similar to other validated ordinal scales, commonly
used in health outcome assessments [50,51]. Recall
bias should be considered while interpreting these re-
sults; patients may have over- or under-estimated the
functional improvements, and therefore the direction
of impact of this bias on our study findings is unclear.
Several study strengths must also be noted. We in-
cluded a large sample size with adequate number of
events to study the question of interest, used validated
measures (questionnaire, Deyo-Charlson index), per-
formed multivariable-adjusted analyses, examined both
2- and 5-year outcomes in primary and revision TKA
and provided results for a clinically meaningful joint-
specific functional improvement outcome.Conclusion
In summary, in this study using a U.S. institutional joint
registry, we found that preoperative depression was
Singh and Lewallen BMC Musculoskeletal Disorders 2014, 15:127 Page 10 of 11
http://www.biomedcentral.com/1471-2474/15/127associated with less improvement in index knee func-
tion 2-years after primary TKA and higher preoperative
Deyo-Charlson index was associated with suboptimal
improvement in knee function 5-years after revision
TKA. These findings clarify the role of medical and psy-
chological comorbidity in functional improvement in
the index knee after TKA. Patients with depression may
benefit by optimization of behavioral and medical ther-
apy for depression prior to and after primary TKA.
Similarly, closer management of medical comorbidities
may have an impact on functional outcomes after revi-
sion TKA. Patients with higher medical comorbidity
load and/or depression should be warned about sub-
optimal knee function outcome. Future results from the
ongoing AHRQ-funded U.S. registry study should help
to identify additional factors associated with functional
outcomes after TKA [46].
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